Navigation Links
Partnership delivers asthma care to children whose care centers were flooded by Katrina
Date:10/20/2011

p>

HEAL Phase II will extend and build upon the lessons learned from the first phase, the most significant of which was that successful childhood asthma management requires access to continuous, evidence-based care that incorporates the home, healthcare setting and school. The program will enroll children (ages 2-18) who receive care at any of the DCSNO clinic locations and the Children's Health Fund-Tulane University Health Sciences Center Department of Pediatrics mobile clinic that currently serves Fredrick Douglas High School and A.D. Crossman Esperanza Charter School. HEAL Phase II will use the following elements to provide coordinated care for children with asthma and their families:

  • Provider Training: Studies have shown that using the National Heart, Lung and Blood Institute asthma guidelines in practice improves health outcomes. HEAL will retain the services of an allergist who will train providers at DCSNO to enhance their skills and help them deliver care that is compliant with these guidelines.
  • Asthma Educators: Asthma educators have been shown to effectively reduce the number of days with symptoms, emergency department visits and hospitalizations. During the program, two asthma educators will provide counseling to children and their families that: 1) addresses the child's specific severity of symptoms, sensitivities and exposures to allergens; 2) identifies and addresses barriers to care and empowers them to acquire the skills to effectively self-manage the disease and communicate with physicians; and, 3) includes follow-up calls between clinic appointments and home visits, where necessary.
  • Electronic Medical Records: The effective use of electronic medical records can improve access to care, doctor-patient communication, efficiency and patient satisfaction. Most importantly they can decrease medical errors. Both DCSNO and CHF will implement important changes to existing electronic medical systems to enhance delivery and docume
    '/>"/>

Contact: Kimberly Wise
kwise@ccapr.com
202‑236‑1404
The Merck Childhood Asthma Network, Inc.
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. EdeniQ and IKA® Works Announce Global Partnership for Biomass Milling Technology
2. EdeniQ and IKA® Works Announce Global Partnership for Biomass Milling Technology
3. Smithsonian Conservation Biology Institute and George Mason University expand partnership
4. Clemson University and the University of Queensland form biofuels research partnership
5. MU signs $5 million agreement with Coulter Translational Research Partnership Program
6. Numera and HealthTrio LLC Form Partnership to Provide Objective Health Information for Millions of Consumers
7. D.C.-area science teachers experimenting with partnerships
8. Optiqua-NTU partnership to develop next-generation sensor technology
9. Partnership of genes affects the brains development
10. Tufts announces public launch of the Tufts Institute for Biomedical Partnerships website/HUB
11. memsys-NTU partnership to enhance water desalination technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... critical security-authentication needs, today announced the beginning of shipments ... solution. The company, based in ... the three-day Connect:ID Expo, which began here today at ... said version 2.0 of its SDK boosts the accuracy ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... fossilized tracksite in southern Africa shows how early dinosaurs ... slippery and sloping terrain. Differences in how early dinosaurs ... of the group. The research, conducted by researchers ... Aires, and the Iziko South African Museum in Cape ...
... risk of allergy. Cathleen Muche-Borowski and her coauthors present ... current issue of Deutsches rzteblatt International (Dtsch ... becoming increasingly common in Western industrialized countries. As there ... hay fever, or atopic eczema, the prevention of these ...
... Va. A five-year-old Virginia Tech outreach program, ... doing research and providing results that scientists can ... Partnership Award from the National Center for Research ... of Health. The Fralin Life Science Institute,s Partnership ...
Cached Biology News:Trackway analysis shows how dinosaurs coped with slippery slopes 2Trackway analysis shows how dinosaurs coped with slippery slopes 3NIH funds new phase of high school-university research partnership 2NIH funds new phase of high school-university research partnership 3
(Date:5/1/2015)... 2015 Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter 2015 financial results will be released on ... market. At 8:30 am Eastern Time, Pfenex management will ... results and provide a business update. A press release ...
(Date:5/1/2015)... 1, 2015 According to ... Product (Equipment, Consumables), by Type (Monoclonal, Polyclonal), by ... Research Institutes) - Analysis & Global Forecast to ... global Antibody Production Market for the forecast period ... to reach $2.572 Billion by 2019 from $1.425 ...
(Date:4/30/2015)... Francisco, CA (PRWEB) April 30, 2015 Cytokinetics, ... the first quarter of 2015 were $4.4 million, compared to ... net loss for the first quarter was $8.9 million, or ... a net loss for the same period in 2014, of ... As of March 31, 2015, cash, cash equivalents and investments ...
(Date:4/30/2015)... 30, 2015 Biodata, producer of ... integrated protocols and specimen management systems, and ChemAxon, ... consulting services for life science research, announce their ... newest feature: chemical structure and reaction support. Already ... biologists, bio-chemists, and more, the integration of ChemAxon's ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8Labguru Integrates ChemAxon's Marvin JS, to Enhance Functionality for Chemists 2
... Agence de Medecine,Preventive (AMP) announced today the appointment ... SIVAC (Supporting Independent Immunization and,Vaccine Advisory Committees) initiative. ... national immunization technical advisory groups in six,resource poor ... committees will help,national health authorities to set up ...
... 12 Synvista Therapeutics, Inc. (NYSE Alternext ... BENEFICIAL study, a Phase 2 double-blind, placebo-controlled, randomized trial of ... the effect of alagebrium on exercise tolerance in patients with ... enrollment of its BREAK ( B eginning a R ...
... ANA, Calif., Jan. 12 ,Abbott ( NYSE: ABT ) and ... a definitive agreement for Abbott to acquire AMO for $22 ... $2.8 billion, inclusive,of estimated net debt at the time of ... leader in ophthalmic care, comprised of three segments: cataract,surgery, laser ...
Cached Biology Technology:French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees) 2French Agency AMP Appoints Dr Kamel Senouci as Director of SIVAC Initiative (Supporting Independent Immunization and Vaccine Advisory Committees) 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 2Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 3Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 2Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 3Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 5Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 6Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 7